These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 10800584

  • 1. [The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia].
    Wojakowski W, Gmiński J, Stajszczyk M, Goss M, Siemianowicz K, Machalski M.
    Przegl Lek; 1999; 56(11):716-9. PubMed ID: 10800584
    [Abstract] [Full Text] [Related]

  • 2. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
    Wojakowski W, Gminski J, Siemianowicz K, Goss M, Machalski M.
    Int J Mol Med; 2000 Nov; 6(5):591-4. PubMed ID: 11029530
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of angiotensin-converting enzyme inhibitor on cefroxadine uptake by rabbit small intestinal brush border membrane vesicles.
    Kitagawa S, Takeda J, Kaseda Y, Sato S.
    Biol Pharm Bull; 1997 Apr; 20(4):449-51. PubMed ID: 9145229
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
    Sun YP, Zhu BQ, Browne AE, Pulukurthy S, Chou TM, Sudhir K, Glantz SA, Deedwania PC, Chatterjee K, Parmley WW.
    J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):175-81. PubMed ID: 11509924
    [Abstract] [Full Text] [Related]

  • 6. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
    Hoshida S, Yamashita N, Kawahara K, Kuzuya T, Hori M.
    Circulation; 1999 Jan 26; 99(3):434-40. PubMed ID: 9918532
    [Abstract] [Full Text] [Related]

  • 7. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Lin CJ, Akarawut W, Smith DE.
    Pharm Res; 1999 May 26; 16(5):609-15. PubMed ID: 10350000
    [Abstract] [Full Text] [Related]

  • 8. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
    Lear W, Ruzicka M, Leenen FH.
    Am J Physiol; 1997 Aug 26; 273(2 Pt 2):H641-6. PubMed ID: 9277479
    [Abstract] [Full Text] [Related]

  • 9. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.
    Benzie IF, Tomlinson B.
    Br J Clin Pharmacol; 1998 Feb 26; 45(2):168-9. PubMed ID: 9491832
    [Abstract] [Full Text] [Related]

  • 10. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.
    Sugano M, Makino N, Yanaga T.
    Atherosclerosis; 1996 Nov 15; 127(1):123-9. PubMed ID: 9006812
    [Abstract] [Full Text] [Related]

  • 11. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O, Bao G, Feelisch M, Unger T, Gohlke P.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):854-63. PubMed ID: 7473177
    [Abstract] [Full Text] [Related]

  • 12. The effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia.
    Mahmoudabady M, Kazemi N, Niazmand S, Rezaee SA, Soukhtanloo M, Hosseini M.
    Pharmacol Rep; 2015 Oct 15; 67(5):837-41. PubMed ID: 26398373
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.
    Hoshida S, Nishida M, Yamashita N, Igarashi J, Aoki K, Hori M, Kuzuya T, Tada M.
    Atherosclerosis; 1997 Apr 15; 130(1-2):53-9. PubMed ID: 9126648
    [Abstract] [Full Text] [Related]

  • 15. Response of aorta connective tissue matrix to injury caused by vassopressin-induced hypertension or hypercholesterolemia.
    Drobnik J, Dabrowski R, Szczepanowska A, Giernat L, Lorenc J.
    J Physiol Pharmacol; 2000 Sep 15; 51(3):521-33. PubMed ID: 11016871
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P.
    J Hypertens; 2002 Dec 15; 20(12):2495-504. PubMed ID: 12473875
    [Abstract] [Full Text] [Related]

  • 18. Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
    Wojewódzka-Zelezniakowicz M, Chabielska E, Mogielnicki A, Kramkowski K, Karp A, Opadczuk A, Domaniewski T, Malinowska-Zaprzałka M, Buczko W.
    J Physiol Pharmacol; 2006 Jun 15; 57(2):231-45. PubMed ID: 16845228
    [Abstract] [Full Text] [Related]

  • 19. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
    Pörsti I, Säynävälammi P, Arvola P, Nurmi AK, Manninen V, Ylitalo P, Vapaatalo H.
    Methods Find Exp Clin Pharmacol; 1986 Sep 15; 8(9):543-6. PubMed ID: 3022083
    [Abstract] [Full Text] [Related]

  • 20. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL, Sorkin EM.
    Drugs; 1994 Aug 15; 48(2):227-52. PubMed ID: 7527326
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.